w.verhoeven
TL2 Moderator · Linköping
Contributes reviews on supplier material. Based in Linköping.
Joined 7 September 2025 · last posted 3d
90 posts, newest first. Showing up to 150.
-
Irish differences from the UK position — what changed since Replied, post #11 · Regional › UK & Ireland · 25 Jul 2026 · 0 likes Picking up post #8: that is the part I would want checked first. Regional variation in NHS: access varies dramatically by region depending on local commissioning…
-
Why the Start Here categories exist, and what they are not for Replied, post #36 · Start Here › Welcome · 25 Jul 2026 · 14 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Request: a per-category review queue Replied, post #124 · Meta › Feature requests · 23 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #20 · Clinical › Bloodwork · 21 Jul 2026 · 0 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #49 · Practice › Interactions · 21 Jul 2026 · 26 likes I read post #47 twice before replying, because I had assumed the opposite. Supplements and herbs: many have no established interaction. Some do. If you are taking…
-
Pooling trials with different estimands Replied, post #108 · Evidence › Meta-analyses · 18 Jul 2026 · 13 likes post #107 answers the question as asked. The question underneath it is different. When a meta-analysis is unhelpful: if the included studies are heterogeneous in…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #107 · Compounds › Semaglutide · 16 Jul 2026 · 23 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Which categories are strict and which are relaxed, honestly Replied, post #16 · Start Here › Welcome · 15 Jul 2026 · 8 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
What a reversed-phase purity number actually is Replied, post #19 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 5 likes This follows post #16 rather than contradicting it. Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #31 · Pharmacology › Receptor biology · 30 Jun 2026 · 28 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
Personal or family history of medullary thyroid carcinoma Replied, post #12 · Safety › Contraindications · 24 Jun 2026 · 11 likes Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring for hypoglycemia. The combination is used with…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #58 · Analytics › Home & field testing · 17 Jun 2026 · 3 likes Picking up post #55: that is the part I would want checked first. Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids.…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #20 · Access › International · 17 Jun 2026 · 8 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Insurance and replacement policies, compared Replied, post #15 · Sourcing › Logistics · 12 Jun 2026 · 16 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Reading an interaction checker output critically Replied, post #3 · Practice › Interactions · 11 Jun 2026 · 15 likes Worth separating two things that the opening post runs together. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #74 · Practice › Administration · 6 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Does a peptide degrade silently, with no visual change? Replied, post #41 · Practice › Storage & stability · 5 Jun 2026 · 10 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
Blind submission and why it changes minds — the long version Replied, post #110 · Sourcing › Independent verification · 31 May 2026 · 30 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
What a good consultation looks like from the other side Replied, post #45 · Clinical › Prescriber conversations · 30 May 2026 · 7 likes post #44 answers the question as asked. The question underneath it is different. Asking about monitoring: understand what lab work will be done, how often, and what you…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #51 · Sourcing › Red flags · 24 May 2026 · 0 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #6 · Compounds › Semaglutide · 17 May 2026 · 6 likes post #5 answers the question as asked. The question underneath it is different. Approved indications differ by jurisdiction and change. As of mid-2026 the…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #44 · Practice › Reconstitution · 8 May 2026 · 1 like Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #99 · Devices › Syringes & needles · 8 May 2026 · 5 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #112 · Compounds › Tirzepatide · 6 May 2026 · 0 likes Picking up post #109: that is the part I would want checked first. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that…
-
Constipation management, with a dietitian's contribution Replied, post #55 · Practice › Side effects · 20 Apr 2026 · 0 likes I read post #53 twice before replying, because I had assumed the opposite. Vomiting: when it is expected (first-dose reactions or early titration) and when it is a…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #6 · Practice › Reconstitution · 19 Apr 2026 · 19 likes I read post #4 twice before replying, because I had assumed the opposite. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10…
-
Follow-up: State-level differences that actually matter Replied, post #63 · Regional › North America · 7 Apr 2026 · 1 like Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries' import rules. The medication is legal but crossing borders with it…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #46 · Data & Tools › Datasets · 3 Apr 2026 · 14 likes Community-collected datasets: some members have compiled datasets from their own experience and shared them. They are self-reported, unblinded, and therefore limited as…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #41 · Analytics › Impurities & related substances · 25 Feb 2026 · 12 likes post #40 answers the question as asked. The question underneath it is different. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier.…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Replied, post #15 · Analytics › Method validation · 24 Feb 2026 · 20 likes On post #11 — agreed on the reasoning, with one qualification. Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to…
-
Request: export my own posts — one year on Replied, post #49 · Meta › Feature requests · 20 Feb 2026 · 13 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #47 · Practice › Dosing & titration · 17 Feb 2026 · 21 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Five questions in one post gets you one answer — how to split them Replied, post #14 · Start Here › How to Ask · 16 Feb 2026 · 7 likes This follows post #11 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Why "dose equivalence" between different incretin analogues is a weak concept Started this topic · Practice › Dosing & titration · 14 Feb 2026 · 16 likes Why "dose equivalence" between different incretin analogues is a weak concept I have a specific reason for asking rather than idle curiosity, and the context is below.…
-
Trifluoroacetate content and its consequences Replied, post #128 · Analytics › Impurities & related substances · 11 Feb 2026 · 0 likes Coming back to post #126, because the follow-up matters more than the original answer. Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds…
-
[2026 update] What a purity-only report leaves out Replied, post #6 · Sourcing › Independent verification · 22 Jan 2026 · 19 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
The most useful thing you learned here that was not the answer you came for Replied, post #11 · Lounge › Off topic · 30 Dec 2025 · 3 likes post #10 is right about the mechanism and I think understates the practical bit. Community norms: if you want to discuss how the community should work (not moderation…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #14 · Start Here › Welcome · 29 Dec 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #54 · Analytics › Impurities & related substances · 25 Nov 2025 · 0 likes post #53 answers the question as asked. The question underneath it is different. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier.…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #50 · Practice › Interactions · 15 Nov 2025 · 10 likes On post #46 — agreed on the reasoning, with one qualification. Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side…
-
Prescription requirements and telehealth models Replied, post #5 · Sourcing › Regulatory · 7 Nov 2025 · 5 likes Worth separating two things that the opening post runs together. Research-use-only status is a legal classification, not a safety classification. It means the compound…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #20 · Compounds › Tirzepatide · 7 Nov 2025 · 18 likes Coming back to post #18, because the follow-up matters more than the original answer. Nausea profile: some people report tirzepatide as less nausea-prone than…
-
Sleep quality changes during weight loss — what changed since Replied, post #44 · Wellbeing › Sleep · 30 Oct 2025 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Personal import allowances, compared — a second dataset Replied, post #15 · Access › International · 29 Oct 2025 · 11 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: What a seizure notice actually says Replied, post #41 · Sourcing › Logistics · 27 Oct 2025 · 3 likes post #40 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #87 · Practice › Storage & stability · 16 Oct 2025 · 10 likes Worth separating two things that post #83 runs together. Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly…
-
Documentation that materially improves an appeal's chances Replied, post #26 · Access › Insurance & coverage · 12 Oct 2025 · 6 likes This follows post #23 rather than contradicting it. Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or…
-
Particulates in a reconstituted solution: identifying the likely source Replied, post #13 · Analytics › Impurities & related substances · 12 Oct 2025 · 19 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
An orphaned page with no inbound links — the long version Replied, post #8 · Meta › Wiki maintenance · 9 Oct 2025 · 13 likes Coming back to post #6, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #37 · Compounds › Oral incretins · 29 Sep 2025 · 23 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #65 · Practice › Side effects · 15 Sep 2025 · 7 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Column chemistry choices for a 40-residue peptide Replied, post #30 · Analytics › HPLC & UHPLC · 7 Sep 2025 · 0 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #9 · Data & Tools › Datasets · 6 Sep 2025 · 30 likes Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #124 · Practice › Storage & stability · 27 Aug 2025 · 5 likes Coming back to post #122, because the follow-up matters more than the original answer. I want to gently push back on the reply above about storage extrapolation. The…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #62 · Clinical › Special populations · 17 Aug 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A request that was declined, and the reasoning — a second dataset Replied, post #71 · Documentation › Wiki requests · 13 Aug 2025 · 7 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #108 · Wellbeing › Mental health · 11 Aug 2025 · 1 like Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters.
-
Follow-up: Why appetite effects are mostly central Replied, post #8 · Pharmacology › Receptor biology · 30 Jul 2025 · 2 likes On post #4 — agreed on the reasoning, with one qualification. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #76 · Clinical › Comorbidities · 21 Jul 2025 · 1 like post #75 answers the question as asked. The question underneath it is different. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #10 · Practice › Storage & stability · 20 Jul 2025 · 26 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Thyroid function tests during substantial weight change Replied, post #8 · Clinical › Bloodwork · 18 Jul 2025 · 0 likes Coming back to post #6, because the follow-up matters more than the original answer. Biological variation: the person-to-person variation in a biomarker for a healthy…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #81 · Outcomes › Progress reports · 17 Jul 2025 · 0 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Counter-ion content and its effect on measured mass Replied, post #72 · Analytics › Mass spectrometry · 23 Jun 2025 · 1 like This follows post #69 rather than contradicting it. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at…
-
Reverting an edit that had no revision note Replied, post #10 · Meta › Wiki maintenance · 13 Jun 2025 · 7 likes Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the maintainer recruit contributors.
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #23 · Evidence › Trials · 9 Jun 2025 · 1 like post #22 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #109 · Clinical › Comorbidities · 9 Jun 2025 · 16 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
Sequence verification for an obscure compound: how it is done Replied, post #48 · Compounds › Other compounds · 30 May 2025 · 0 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #57 · Compounds › Other compounds · 23 May 2025 · 0 likes This follows post #54 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
A claim built entirely on a subgroup analysis Replied, post #33 · Evidence › Study critique · 13 May 2025 · 1 like Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
Lean mass preservation: what the evidence supports Replied, post #14 · Outcomes › Body composition · 13 May 2025 · 5 likes Coming back to post #12, because the follow-up matters more than the original answer. Maintenance phase: tracking body composition during maintenance (weight stable) is…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #115 · Evidence › Journal club · 22 Apr 2025 · 1 like TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #73 · Practice › Reconstitution · 7 Apr 2025 · 21 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #82 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #63 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Validating a method you did not develop — does this still hold? Replied, post #123 · Analytics › Method validation · 16 Mar 2025 · 3 likes post #122 answers the question as asked. The question underneath it is different. System suitability: injections run at the start of a batch to establish that the…
-
Charge states for a 4 kDa peptide, worked through Replied, post #114 · Analytics › Mass spectrometry · 15 Mar 2025 · 2 likes I read post #112 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
When "no data" is the complete and final answer Replied, post #111 · Compounds › Other compounds · 7 Mar 2025 · 0 likes post #110 is right about the mechanism and I think understates the practical bit. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #7 · Practice › Interactions · 4 Mar 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #41 · Sourcing › Regulatory · 1 Mar 2025 · 12 likes On post #37 — agreed on the reasoning, with one qualification. Regulatory positions change: a compound's status today might differ from its status a year from now.…
-
Validating a method you did not develop — does this still hold? Replied, post #38 · Analytics › Method validation · 23 Feb 2025 · 4 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Scheduled maintenance and what will be unavailable Replied, post #42 · Meta › Announcements · 13 Feb 2025 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A promotion I argued against, and why I lost Replied, post #54 · Documentation › Doc review · 7 Jan 2025 · 4 likes post #53 answers the question as asked. The question underneath it is different. Review date disputes: if a maintained page's review date is approaching and it has not…
-
Oxidation pathways for methionine and tryptophan Replied, post #31 · Analytics › Impurities & related substances · 28 Dec 2024 · 5 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #17 · Evidence › Journal club · 21 Dec 2024 · 12 likes This follows post #14 rather than contradicting it. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the…
-
Coming back to: When to suspect the method rather than the sample Replied, post #27 · Analytics › Method validation · 4 Dec 2024 · 26 likes Coming back to post #25, because the follow-up matters more than the original answer. Forced degradation studies: deliberately stress the material with acid, base,…
-
Revisiting: US compounding rules and how they changed Replied, post #10 · Regional › North America · 11 Sep 2024 · 2 likes I read post #8 twice before replying, because I had assumed the opposite. Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both…
-
Coming back to: What consumer-accessible tests can and cannot determine Replied, post #3 · Analytics › Home & field testing · 31 Aug 2024 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. False positives and false negatives: no test has 100% sensitivity and 100% specificity.…
-
Pen wastage and its effect on real cost Started this topic · Access › Pricing · 8 Jun 2024 · 0 likes Pen wastage and its effect on real cost Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail…
-
How this community labels and discusses unrefereed work Replied, post #5 · Evidence › Preprints · 5 Jun 2024 · 23 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #3 · marked as the solution · Practice › Dosing & titration · 20 May 2024 · 7 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…